Simeprevir once daily with peginterferon -2 a/ribavirin significantly improved sustained virologic response rate 12 weeks after treatment end in treatment-nave patients with chronic hepatitis C virus genotype 1 infection , with a shorter 24-week treatment duration in most patients .